09/10/2007 - 09:12

pSivida opens enrolments for macular edema treatment trials

09/10/2007 - 09:12

Bookmark

Save articles for future reference.

Perth-based biotechnology company pSivida Ltd has completed enrolment for the first studies of absorption, distribution and metabolism of its diabetic macular edema treatment Medidur, the company has announced.

To read our articles you will need to either login or subscribe.

STANDING BY BUSINESS. TRUSTED BY BUSINESS.

Subscription Options